Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Options include establishing career trajectory plans and offering smooth onboarding for incoming laboratory scientists
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
How a new automated system bringing MS to routine lab testing could help set laboratories apart from their competitors
Pre-submission and Q-Submission meetings apparently have been halted, for now
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons
Steps that lab leaders, mentors, and mentees can take when establishing mentorships
Tips for mentors and mentees in medical laboratories on how to establish these professional relationships
How the 2024 proposal will fare on Capitol Hill in 2025 remains to be seen, though